Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

114.45 +1.05 (+0.93%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,188,003
Open 112.64
Bid (Size) 112.85 (1)
Ask (Size) 115.90 (1)
Prev. Close 113.40
Today's Range 112.50 - 114.73
52wk Range 92.43 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbbVie’s Dividend Isn’t As Scary As It Looks
AbbVie currently pays shareholders a quarterly dividend of $1.55 per share, which gives the stock a 3.3% yield on the current price. 
Via Talk Markets
3 Dividend Growth Stocks You Can Buy and Hold Forever
These healthcare stocks have fantastic dividend track records. 
Via The Motley Fool

Performance

YTD
+4.19%
+4.19%
1 Month
+0.39%
+0.39%
3 Month
+8.03%
+8.03%
6 Month
+7.68%
+7.68%
1 Year
+21.05%
+21.05%

More News

Read More
Beat the Nasdaq With This Cash-Gushing Dividend Stock
Via The Motley Fool
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Via The Motley Fool
MarketBeat Week in Review – 10/14 - 10/18
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Is Abbott Laboratories Stock a Buy?
Via The Motley Fool
Price Over Earnings Overview: Abbott Laboratories
Via Benzinga
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
Via The Motley Fool
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
Via Benzinga
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
Via Benzinga
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
Via Benzinga
Abbott Labs Earnings Edge Past Q3 Views, Led By Medical Devices
Via Investor's Business Daily
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Why Abbott Laboratories Stock Was a Winner on Wednesday
Via The Motley Fool
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Tech Stocks Stall, Small Caps Surge As Regional Banks Rally, Airlines Rocket: What's Driving Markets Wednesday?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
Via Benzinga
Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
Via MarketBeat
Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast
Via Benzinga
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
Via Benzinga
Topics Stocks
Exposures US Equities
Abbott Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Nasdaq Dips 1% Amid Plunge In Chipmaker Stocks: Fear & Greed Index Moves To 'Greed' Zone
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.